RecruitingNCT07349251
Normal Hemostasis Values in Premature Infants
Sponsor
University Hospital, Strasbourg, France
Enrollment
1,000 participants
Start Date
Nov 24, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.
Eligibility
Min Age: 0 MonthsMax Age: 18 Months
Inclusion Criteria1
- Patients aged 18 months or younger for whom a sample was sent to the Hematology Laboratory at Strasbourg University Hospital for measurement of a hemostasis parameter
Exclusion Criteria2
- Patients with incomplete data
- Patients with a congenital hemostasis disorder (hemophilia A or B, von Willebrand disease), a coagulopathy, or hepatocellular insufficiency
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07349251